Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
作者信息
Jaffe N
出版信息
Cancer Chemother Rep. 1974 Mar-Apr;58(2):275-80.
PMID:4598245
Abstract
摘要
相似文献
1
Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.大剂量甲氨蝶呤（NSC-740）联合亚叶酸钙解救治疗转移性骨肿瘤的进展报告
Cancer Chemother Rep. 1974 Mar-Apr;58(2):275-80.
2
"Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
Cancer Treat Rep. 1978 Feb;62(2):233-5.
3
Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.骨肉瘤的甲氨蝶呤辅助治疗及甲酰四氢叶酸治疗
N Engl J Med. 1974 Nov 7;291(19):994-7. doi: 10.1056/NEJM197411072911902.
4
The role of high-dose methotrexate with citrovorum factor "rescue" in the treatment of osteogenic sarcoma.大剂量甲氨蝶呤联合亚叶酸钙“解救”在骨肉瘤治疗中的作用
Int J Radiat Oncol Biol Phys. 1977 Mar-Apr;2(3-4):261-6. doi: 10.1016/0360-3016(77)90083-9.
5
High-dose methotrexate in osteogenic sarcoma: a 5-year experience.高剂量甲氨蝶呤治疗骨肉瘤：5年经验
Cancer Treat Rep. 1978 Feb;62(2):259-64.
6
High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.大剂量甲氨蝶呤联合亚叶酸钙解救及阿霉素治疗儿童骨肉瘤
Cancer. 1974 Apr;33(4):1151-63. doi: 10.1002/1097-0142(197404)33:4<1151::aid-cncr2820330439>3.0.co;2-8.
7
Adjuvant chemotherapy for osteogenic sarcoma.骨肉瘤的辅助化疗
Cancer Treat Rep. 1978 Feb;62(2):283-7.
8
Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.转移性骨肉瘤对大剂量甲氨蝶呤冲击治疗联合亚叶酸钙解救及放射治疗的良好反应。
Cancer. 1973 Jun;31(6):1367-73. doi: 10.1002/1097-0142(197306)31:6<1367::aid-cncr2820310611>3.0.co;2-6.
9
Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma: pre-surgical treatment of primary tumor and of overt pulmonary metastases.
Cancer. 1977 Jan;39(1):45-50. doi: 10.1002/1097-0142(197701)39:1<45::aid-cncr2820390109>3.0.co;2-t.
10
The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.多药化疗治疗骨肉瘤的理论依据。
Cancer. 1975 Mar;35(3 suppl):936-45. doi: 10.1002/1097-0142(197503)35:3+<936::aid-cncr2820350714>3.0.co;2-b.
引用本文的文献
1
Dissecting the Role of Circular RNAs in Sarcomas with Emphasis on Osteosarcomas.剖析环状RNA在肉瘤中的作用，重点关注骨肉瘤
Biomedicines. 2021 Nov 8;9(11):1642. doi: 10.3390/biomedicines9111642.
2
Osteosarcoma: evolution of treatment paradigms.骨肉瘤：治疗模式的演变
Sarcoma. 2013;2013:203531. doi: 10.1155/2013/203531. Epub 2013 May 27.
3
Methotrexate for high-grade osteosarcoma in children and young adults.甲氨蝶呤用于儿童和青年的高级别骨肉瘤治疗。
Cochrane Database Syst Rev. 2011 May 11;2011(5):CD006325. doi: 10.1002/14651858.CD006325.pub3.
4
Effect of methotrexate concentration and exposure time on mammalian cell survival in vitro.甲氨蝶呤浓度和暴露时间对体外培养的哺乳动物细胞存活的影响。
Br J Cancer. 1980 Feb;41(2):277-84. doi: 10.1038/bjc.1980.40.
5
A pharmacokinetic model for high-dose methotrexate infusions in man.人体高剂量甲氨蝶呤输注的药代动力学模型。
J Pharmacokinet Biopharm. 1977 Oct;5(5):421-33. doi: 10.1007/BF01061726.
6
Pharmacokinetic and clinical studies of 24-h infusions of high-dose methotrexate.大剂量甲氨蝶呤24小时输注的药代动力学和临床研究。
Cancer Chemother Pharmacol. 1978;1(1):61-4. doi: 10.1007/BF00253148.
Zotero 插件